TwinsTT Unveils FURCAST for Smarter Pet Chronic Care

As the global pet population continues to age, the prevalence of chronic diseases—such as Chronic Kidney Disease (CKD)—is rising steadily. Traditional health management approaches based on single-point diagnostics are increasingly insufficient to meet the needs of long-term care. In response, pet healthcare is transitioning from episodic assessment toward data-driven analysis and predictive modeling.

TwinsTT, a Taiwan-based pet health technology company, officially unveiled its proprietary FURCAST AI Disease Trajectory Inference System at InnoVEX 2026, introducing a new approach to chronic disease management through artificial intelligence and time-series analytics. FURCAST integrates longitudinal blood test data—including biomarkers such as SDMA and creatinine—with health records to construct individualized disease progression models. The system transforms fragmented clinical data into intuitive, visualized disease trajectories. Unlike conventional approaches that rely on single-point readings, FURCAST emphasizes trend analysis and trajectory-based insights, enabling pet owners and veterinary professionals to better understand disease progression and enhance risk identification.

According to TwinsTT, the current pet healthcare market remains largely focused on nutritional supplementation and symptomatic relief, while applications involving long-term data integration and predictive analytics are still limited. FURCAST is designed to address this gap by providing a more systematic decision-support tool, facilitating a shift from reactive care to proactive health management.

From an application perspective, FURCAST is expected to support multiple use cases, including:

• Consumer-facing pet health management services (B2C)
• Clinical decision support for veterinary professionals (B2B)
• Data-driven solutions for industry stakeholders (B2B2C)

The company noted that integrating these use cases can help establish cross-functional data connectivity and gradually build high-value health data assets.

TwinsTT further observed that many pet owners face uncertainty when managing chronic conditions due to fragmented information and high barriers to interpretation. By converting complex data into visualized trends, FURCAST lowers the threshold for understanding and enables users to make more informed decisions regarding their pets’ health.

Looking ahead, TwinsTT plans to further expand the integration of artificial intelligence and health data, extending its applications to a broader range of chronic conditions. The company aims to enhance the quality of pet healthcare while accelerating digital transformation across the industry.

——————————————————

TwinsTT is a technology-driven company specializing in pet health and data analytics. The company is committed to developing AI-powered solutions for chronic disease management through the application of longitudinal health data, with the goal of advancing innovation in pet healthcare.